BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres

被引：4
作者：
Ghesquieres, Herve [1 ,2 ]
Dalban, Cecile [3 ]
Nicolas-Virelizier, Emmanuelle [1 ]
Jardin, Fabrice [4 ]
Le Bras, Fabien [5 ]
Le Gouill, Steven [6 ]
Casasnovas, Olivier [7 ,8 ]
Vizoso, Seraphine [3 ]
Hernandez, Caroline [3 ]
Metzger, Severine [3 ]
Perol, David [3 ]
Cartron, Guillaume [9 ]
机构：
[1] Univ Claude Bernard Lyon 1, Dept Hematol, Ctr Leon Berard, Lyon, France
[2] Univ Claude Bernard Lyon 1, Hop Lyon Sud, Dept Hematol, Pierre Benite, France
[3] Ctr Leon Berard, Dept Clin Res & Innovat, Lyon, France
[4] Univ Rouen, U1245, INSERM, Ctr Henri Becquerel,IRIB, Rouen, France
[5] CHU Henri Mondor, Dept Hematol, Creteil, France
[6] Univ Nantes, NeXT, Serv Hematol Clin, CHU Nantes,INSERM,CRCINA Nantes Angers, Nantes, France
[7] CHU Dijon Bourgogne, Dept Hematol, Dijon, France
[8] INSERM 1231, Dijon, France
[9] Univ Montpellier, CHU Montpellier, UMR 5535, Dept Hematol, Montpellier, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 192卷 / 03期
关键词：
D O I：
10.1111/bjh.17279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E94 / E98
页数：5
相关论文
共 12 条
  • [1] Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers
    Chantepie, Sylvain P.
    Garciaz, Sylvain
    Tchernonog, Emmanuelle
    Peyrade, Frederic
    Larcher, Marie-Virginie
    Diouf, Momar
    Fornecker, Luc-Mathieu
    Houot, Roch
    Gastinne, Thomas
    Soussain, Carole
    Malak, Sandra
    Lemal, Richard
    Delette, Caroline
    Ibrahim, Ahmad
    Gac, Anne-Claire
    Reboursiere, Emilie
    Vilque, Jean-Pierre
    Bekadja, Mohamed-Amine
    Casasnovas, Rene-Olivier
    Gressin, Remy
    Guidez, Stephanie
    Coso, Diane
    Herbaux, Charles
    Yakoub-Agha, Ibrahim
    Bouabdallah, Krimo
    Durot, Eric
    Damaj, Gandhi
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (06) : 729 - 735
  • [2] Chow VA, 2019, HEMATOL-AM SOC HEMAT, P287, DOI 10.1182/hematology.2019000033
  • [3] Dreyling M, 2014, ANN ONCOL, V25, P76, DOI [10.1093/annonc/mdu200, 10.1093/annonc/mdx020]
  • [4] Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity
    Garciaz, S.
    Coso, D.
    de Collela, J-M Schiano
    Broussais, F.
    Stoppa, A-M
    Aurran, T.
    Chabannon, C.
    Helvig, A.
    Xerri, L.
    Blaise, D.
    Bouabdallah, R.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (02) : 319 - 321
  • [5] Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
    Hueso, Thomas
    Gastinne, Thomas
    Garciaz, Sylvain
    Tchernonog, Emmanuelle
    Delette, Caroline
    Casasnovas, Rene-Olivier
    Durot, Eric
    Houot, Roch
    Tessoulin, Benoit
    Tournilhac, Olivier
    Malak, Sandra
    Gyan, Emmanuel
    Fornecker, Luc-Matthieu
    Abraham, Julie
    Delapierre, Baptiste
    Peyrade, Frederic
    Lemal, Richard
    Gressin, Remy
    Chantepie, Sylvain
    Borel, Cecile
    Morello, Remy
    Bouabdallah, Krimo
    Ibrahim, Ahmad
    Bouabdallah, Reda
    Le Gouill, Steven
    Damaj, Gandhi
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1076 - 1084
  • [6] Jacobson CA, 2019, HEMATOL-AM SOC HEMAT, P279, DOI 10.1182/hematology.2019000032
  • [7] Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality
    Lucijanic, Marko
    Prka, Zeljko
    Jaksic, Ozren
    Mitrovic, Zdravko
    Vrkljan, Anamarija
    Pejsa, Vlatko
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (02) : E42 - E43
  • [8] Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
    Redondo, Alba M.
    Valcarce, David
    Gonzalez-Rodriguez, Ana P.
    Suarez-Lledo, Maria
    Bello, Jose L.
    Canales, Miguel
    Gayoso, Jorge
    Colorado, Mercedes
    Jarque, Isidro
    del Campo, Raquel
    Arranz, Reyes
    Terol, Maria J.
    Rifon, Jose J.
    Rodriguez, Maria J.
    Ramirez, Maria J.
    Castro, Nerea
    Sanchez, Andres
    Lopez-Jimenez, Javier
    Montes-Moreno, Santiago
    Briones, Javier
    Lopez, Aurelio
    Palomera, Luis
    Lopez-Guillermo, Armando
    Caballero, Dolores
    Martin, Alejandro
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (05) : 797 - 807
  • [9] A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience
    Saleh, Khalil
    Danu, Alina
    Koscielny, Serge
    Legoupil, Clemence
    Pilorge, Sylvain
    Castilla-Llorente, Cristina
    Ghez, David
    Lazarovici, Julien
    Michot, Jean-Marie
    Khalife-Saleh, Nadine
    Lapierre, Valerie
    Alenxandrova, Kamelia
    Arfi-Rouche, Julia
    Bourhis, Jean-Henri
    Ribrag, Vincent
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2580 - 2587
  • [10] High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation
    Tsang, Erica S.
    Villa, Diego
    Loscocco, Federica
    Visani, Giuseppe
    Power, Maryse
    Guiducci, Barbara
    Clissa, Cristina
    Song, Kevin
    Toze, Cynthia
    Abou Mourad, Yasser
    Sutherland, Heather
    Sanford, David
    Nantel, Stephen H.
    Sehn, Laurie H.
    Scott, David W.
    Savage, Kerry J.
    Connors, Joseph M.
    Gerrie, Alina S.
    Isidori, Alessandro
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 (03) : 481 - 484
12